Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Commissioner’s National Priority Voucher Program Reflects US FDA Review Politicization, Pazdur Says
Jan 14 2026
•
By
Sue Sutter
The FDA firewall between political appointees and review decisions has been breached, Richard Pazdur said.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Review Pathways
More from United States